Serum triamcinolone levels during intensive, inpatient wet-dressing therapy.

Abstract

Wet dressings combined with topical corticosteroids are beneficial for patients with generalized and refractory dermatosis; however, to our knowledge, serum levels after topical corticosteroid absorption during intensive therapy have not been reported previously. To examine serum levels of triamcinolone acetonide (TAC) after topical corticosteroid application during intensive wet-dressing therapy. We performed a retrospective study of adult patients admitted for inpatient wet-dressing therapy from 7 November 2015 to 24 June 2016. Data were collected on sex, age, body surface area, TAC serum levels, number of wet-dressing changes after 24 and 48h, and type of wet dressing. In total, 29 patients (14 men, 15 women) were assessed. Median [interquartile range (IQR)] age was 57years (51.5-67.0years) and involved body surface area was 1.98m2 (1.88-2.15)m2 . Before the 24-hour blood draw, patients had received 1-3 dressing changes. Median (IQR) TAC level at 24h was 0.33µg/dL (0.20-0.58µg/dL), with no significant difference noted between the number of dressing changes and TAC serum level. At 48h, results of a serum TAC test were available for 22 patients with 2-6 dressing changes. Mean (IQR) serum level was 0.30µg/dL (0.30-0.87µg/dL). For each additional dressing change, there was an estimated 0.21µg/dL increase in TAC serum level (95% CI 0.11-0.31; P<0.001). TAC serum level was not significantly associated with sex, age, body surface area or dressing type. Intensive, inpatient wet-dressing therapy is associated with detectable TAC serum levels. However, we suspect that topical TAC has a primarily local therapeutic effect on the skin.